Compare CRK & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRK | IRTC |
|---|---|---|
| Founded | 1983 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 5.8B |
| IPO Year | N/A | 2016 |
| Metric | CRK | IRTC |
|---|---|---|
| Price | $22.96 | $179.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | $21.90 | ★ $204.64 |
| AVG Volume (30 Days) | ★ 2.7M | 420.1K |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $1,800,349,000.00 | $702,573,000.00 |
| Revenue This Year | $54.97 | $27.20 |
| Revenue Next Year | $19.34 | $16.91 |
| P/E Ratio | $102.68 | ★ N/A |
| Revenue Growth | ★ 38.73 | 25.45 |
| 52 Week Low | $14.65 | $86.19 |
| 52 Week High | $31.17 | $212.00 |
| Indicator | CRK | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 55.28 |
| Support Level | $21.00 | $175.79 |
| Resistance Level | $24.70 | $182.38 |
| Average True Range (ATR) | 0.89 | 4.38 |
| MACD | 0.04 | 0.87 |
| Stochastic Oscillator | 55.31 | 77.09 |
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.